scispace - formally typeset
M

Mutsuhiro Takekawa

Researcher at University of Tokyo

Publications -  63
Citations -  6200

Mutsuhiro Takekawa is an academic researcher from University of Tokyo. The author has contributed to research in topics: MAPK/ERK pathway & MAP kinase kinase kinase. The author has an hindex of 31, co-authored 57 publications receiving 5794 citations. Previous affiliations of Mutsuhiro Takekawa include Sapporo Medical University & National Presto Industries.

Papers
More filters
Journal ArticleDOI

A Family of Stress-Inducible GADD45-like Proteins Mediate Activation of the Stress-Responsive MTK1/MEKK4 MAPKKK

TL;DR: It is proposed that the GADD45-like proteins mediate activation of the p38/JNK pathway, via MTK1/ MEKK4, in response to environmental stresses.
Journal ArticleDOI

Activation of yeast PBS2 MAPKK by MAPKKKs or by binding of an SH3-containing osmosensor.

TL;DR: The role of mitogen-activated protein (MAP) kinase cascades in integrating distinct upstream signals was studied in yeast and mutants that were not able to activate PBS2 MAP kinase kinase (MAPKK; Pbs2p) at high osmolarity were characterized.
Journal ArticleDOI

Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways

TL;DR: It is reported that SG formation negatively regulates the SAPK apoptotic response, and that the signalling scaffold protein RACK1 functions as a mediator between the two responses.
Journal ArticleDOI

NF‐κB inhibits TNF‐induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death

TL;DR: It is demonstrated here that TNF stimulation leads to accumulation of reactive oxygen species (ROS), which is essential for prolonged mitogen‐activated protein kinase (MAPK) activation and cell death.
Journal ArticleDOI

p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation.

TL;DR: It is reported that a member of the protein phosphatase type 2C family, Wip1, has a role in down‐regulating p38‐p53 signaling during the recovery phase of the damaged cells.